ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.646,84
0,73%
S&P 500
6.114,63
-0,01%
Dow Jones
44.546,08
-0,37%
Euro vs US Dollar
1,04757
-0,19%
Bitcoin
96.166,62
0,04%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Cardiff Oncology Inc (CRDF) Börsenkurse

Cardiff Oncology Inc

Cardiff Oncology Inc (CRDF)

NASDAQ
4,29
0,14
(3,37%)
Geschlossen 17 Februar 10:00PM
Verzögert um 15 Minuten
4,31
0,02
(0,47%)
Nach Börsenschluss: 1:52AM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
4,31
Gebot
4,31
Fragen
4,32
Volumen
494.703
4,135 Tagesbereich 4,29
1,65 52-Wochen-Bereich 6,42
Marktkapitalisierung
220,386M
Handelsende
4,15
Handelsbeginn
4,21
Letzte Trade
100
@
4.31
(formt)
Letzter Handelszeitpunkt
Finanzvolumen
US$ 2.078.440
VWAP
4,2014
Durchschnittliches Volumen (3 Mio.)
2.208.941
Ausgegebene Aktien
51.133.747
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,47
Gewinn pro Aktie (EPS)
-0,81
Erlöse
488k
Nettogewinn
-41,47M

Über Cardiff Oncology Inc

Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias. Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias.

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
cardiffoncology.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Cardiff Oncology Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker CRDF. The last closing price for Cardiff Oncology was US$4,15. Over the last year, Cardiff Oncology shares have traded in a share price range of US$ 1,65 to US$ 6,42.

Cardiff Oncology currently has 51.133.747 shares in issue. The market capitalisation of Cardiff Oncology is US$212,21 million. Cardiff Oncology has a price to earnings ratio (PE ratio) of -1.47.

CRDF Neueste Nachrichten

Weitere Nachrichten

Form 8-K - Current report
Edgar (US Regulatory)
06 Januar 2025
CRDF (3,37%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
18 Dezember 2024
CRDF (3,37%)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
17 Dezember 2024
CRDF (3,37%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
16 Dezember 2024
CRDF (3,37%)

Form 8-K - Current report
Edgar (US Regulatory)
10 Dezember 2024
CRDF (3,37%)

Form 8-K - Current report
Edgar (US Regulatory)
10 Dezember 2024
CRDF (3,37%)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.25-5.482456140354.564.6654.018586224.36406899CS
40.8524.56647398843.464.82993.259337723.98619618CS
121.8172.42.55.63952.2622089413.88560701CS
262.0288.20960698692.295.63952.0913285883.60109764CS
522.6152.0467836261.716.421.6513065313.58533802CS
1561.238.58520900323.116.420.947776072.84614022CS
2602.45131.7204301081.8625.50.7019108575.90559763CS

CRDF - Frequently Asked Questions (FAQ)

What is the current Cardiff Oncology share price?
The current share price of Cardiff Oncology is US$ 4,31
How many Cardiff Oncology shares are in issue?
Cardiff Oncology has 51.133.747 shares in issue
What is the market cap of Cardiff Oncology?
The market capitalisation of Cardiff Oncology is USD 212,21M
What is the 1 year trading range for Cardiff Oncology share price?
Cardiff Oncology has traded in the range of US$ 1,65 to US$ 6,42 during the past year
What is the PE ratio of Cardiff Oncology?
The price to earnings ratio of Cardiff Oncology is -1,47
What is the cash to sales ratio of Cardiff Oncology?
The cash to sales ratio of Cardiff Oncology is 125,26
What is the reporting currency for Cardiff Oncology?
Cardiff Oncology reports financial results in USD
What is the latest annual turnover for Cardiff Oncology?
The latest annual turnover of Cardiff Oncology is USD 488k
What is the latest annual profit for Cardiff Oncology?
The latest annual profit of Cardiff Oncology is USD -41,47M
What is the registered address of Cardiff Oncology?
The registered address for Cardiff Oncology is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Cardiff Oncology website address?
The website address for Cardiff Oncology is cardiffoncology.com
Which industry sector does Cardiff Oncology operate in?
Cardiff Oncology operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
JTAIJet AI Inc
US$ 6,02
(133,33%)
104,48M
SRMSRM Entertainment Inc
US$ 0,6999
(95,50%)
254,39M
WRDWeRide Inc
US$ 31,4877
(83,39%)
21,07M
INLFINLIF Limited
US$ 16,27
(80,58%)
7,68M
MBRXMoleculin Biotech Inc
US$ 2,1201
(66,94%)
136,66M
BLACBellevue Life Sciences Acquisition Corporation
US$ 3,08
(-56,31%)
430,77k
BLACUBellevue Life Sciences Acquisition Corporation
US$ 3,36
(-52,68%)
5,21k
CSAICloudastructure Inc
US$ 19,0001
(-49,58%)
1,03M
NEXNNexxen International Ltd
US$ 10,30
(-49,16%)
164,82k
BSLKBolt Projects Holdings Inc
US$ 0,6626
(-46,13%)
13,4M
CNSPCNS Pharmaceuticals Inc
US$ 0,1415
(31,26%)
480,49M
MGOLMGO Global Inc
US$ 0,7176
(-15,08%)
411,17M
SRMSRM Entertainment Inc
US$ 0,6999
(95,50%)
248,48M
INTCIntel Corporation
US$ 23,60
(-2,20%)
225,04M
NVDANVIDIA Corporation
US$ 138,85
(2,63%)
189,56M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
CRDF
Cardiff Oncology
EU
CS
Axa
USOTC
IDCBY
Industrial and Commercia... (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten